Tipranavir, or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) manufactured by Boehringer-Ingelheim under the trade name Aptivus. It is administered ...
Drug information on Tipranavir for patients and consumers. Drug information on Tipranavir for patients and consumers.
Easy to read patient leaflet for tipranavir. Includes indications, proper use, special instructions, precautions, and possible side effects.
Approval: Tipranavir received FDA approval in June 2005 for use in combination with ritonavir in adults with HIV infection. In 2008, it received approval for children ...
Learn about the prescription medication Aptivus (Tipranavir), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
Introduction . Tipranavir is an antiretroviral protease inhibitor used in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired ...
tipranavir Aptivus Pharmacologic class: Nonpeptidic protease inhibitor of human immunodeficiency virus type 1 (HIV-1) Therapeutic class: Antiretroviral Pregnancy risk ...
Professional guide for Tipranavir. Includes: pharmacology, pharmacokinetics, contraindications, interactions, adverse reactions and more.
Tipranavir (taken with ritonavir [Norvir]) may cause bleeding in the brain. This condition may be life-threatening. Tell your doctor if you have recently had surgery ...
Aptivus (tipranavir) Pronunciation(s): AP-tih-vus; ti-PRAN-a-veer. What is Aptivus? Aptivus is an HIV medication. It is in a category of HIV medicines called protease ...